FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136124773> ?p ?o ?g. }

• W3136124773 abstract "Abstract Background Diabetes mellitus is a common comorbidity of atrial fibrillation (AF), which can complicate the management of AF. The pharmacology of oral anticoagulants (OACs) have been implicated in pathogenesis of diabetes, but the relationship between different OACs and risk of diabetes remains unexamined. This study aimed to evaluate the risk of diabetes with use of different OACs in AF patients. Methods Population-based retrospective cohort study using an electronic healthcare database managed by the Hong Kong Hospital Authority. Patients newly diagnosed with AF from 2014 through 2018 and prescribed OACs were included and followed till December 31, 2019. Inverse probability of treatment weighting based on the propensity score (PS) is used to address potential bias due to nonrandomized allocation of treatment. The risks ofdiabetes were compared between different new OAC users using propensity score-weighted cumulative incidence differences (CID). Results There were 13,688 new users of OACs (warfarin: n = 3454; apixaban: n = 3335; dabigatran: n = 4210; rivaroxaban: n = 2689). The mean age was 75.0 (SD, 11.2), and 6,550 (47.9%) were women. After a median follow-up of 0.93 years (interquartile range, 0.21–1.92 years), 698 incident diabetes cases were observed. In Cox-regression analysis, dabigatran use was significantly associated with reduced risk of diabetes when compared with warfarin use [HR 0.69 (95% CI 0.56–0.86; P < 0.001)], with statistically insignificant associations observed for use of apixaban and rivaroxaban. The corresponding adjusted CIDs at 2 years after treatment with apixaban, dabigatran, and rivaroxaban users when compared with warfarin were − 2.06% (95% CI − 4.08 to 0.16%); − 3.06% (95% CI − 4.79 to − 1.15%); and − 1.8% (− 3.62 to 0.23%). In head-to-head comparisons between women DOAC users, dabigatran was also associated with a lower risk of diabetes when compared with apixaban and rivaroxaban. Conclusions Among adults with AF receiving OACs, the use of dabigatran had the lowest risk of diabetes when compared with warfarin use." @default.
• W3136124773 created "2021-03-29" @default.
• W3136124773 creator A5010329388 @default.
• W3136124773 creator A5011053811 @default.
• W3136124773 creator A5014845843 @default.
• W3136124773 creator A5017159153 @default.
• W3136124773 creator A5025936391 @default.
• W3136124773 creator A5035152212 @default.
• W3136124773 creator A5076157457 @default.
• W3136124773 creator A5083733382 @default.
• W3136124773 creator A5088579117 @default.
• W3136124773 date "2021-03-25" @default.
• W3136124773 modified "2023-10-02" @default.
• W3136124773 title "Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population‐based cohort study" @default.
• W3136124773 cites W1971400919 @default.
• W3136124773 cites W1980740451 @default.
• W3136124773 cites W1999822211 @default.
• W3136124773 cites W2014178867 @default.
• W3136124773 cites W2036193982 @default.
• W3136124773 cites W2048470090 @default.
• W3136124773 cites W2048565444 @default.
• W3136124773 cites W2060546728 @default.
• W3136124773 cites W2073025399 @default.
• W3136124773 cites W2091656140 @default.
• W3136124773 cites W2092322472 @default.
• W3136124773 cites W2100376056 @default.
• W3136124773 cites W2119905591 @default.
• W3136124773 cites W2126049444 @default.
• W3136124773 cites W2128136679 @default.
• W3136124773 cites W2129772862 @default.
• W3136124773 cites W2146878009 @default.
• W3136124773 cites W2149112674 @default.
• W3136124773 cites W2159271270 @default.
• W3136124773 cites W2160738475 @default.
• W3136124773 cites W2234629397 @default.
• W3136124773 cites W2313826353 @default.
• W3136124773 cites W2345328813 @default.
• W3136124773 cites W2580460079 @default.
• W3136124773 cites W2598097718 @default.
• W3136124773 cites W2606162097 @default.
• W3136124773 cites W2735301415 @default.
• W3136124773 cites W2749861182 @default.
• W3136124773 cites W2753486080 @default.
• W3136124773 cites W2794587197 @default.
• W3136124773 cites W2794997419 @default.
• W3136124773 cites W2801052314 @default.
• W3136124773 cites W2864778399 @default.
• W3136124773 cites W2893745569 @default.
• W3136124773 cites W2897368619 @default.
• W3136124773 cites W2969786006 @default.
• W3136124773 cites W2980108101 @default.
• W3136124773 cites W2980622701 @default.
• W3136124773 cites W3007112529 @default.
• W3136124773 cites W3024237297 @default.
• W3136124773 cites W3094749662 @default.
• W3136124773 doi "https://doi.org/10.1186/s12933-021-01263-0" @default.
• W3136124773 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7993481" @default.
• W3136124773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33766030" @default.
• W3136124773 hasPublicationYear "2021" @default.
• W3136124773 type Work @default.
• W3136124773 sameAs 3136124773 @default.
• W3136124773 citedByCount "10" @default.
• W3136124773 countsByYear W31361247732021 @default.
• W3136124773 countsByYear W31361247732022 @default.
• W3136124773 countsByYear W31361247732023 @default.
• W3136124773 crossrefType "journal-article" @default.
• W3136124773 hasAuthorship W3136124773A5010329388 @default.
• W3136124773 hasAuthorship W3136124773A5011053811 @default.
• W3136124773 hasAuthorship W3136124773A5014845843 @default.
• W3136124773 hasAuthorship W3136124773A5017159153 @default.
• W3136124773 hasAuthorship W3136124773A5025936391 @default.
• W3136124773 hasAuthorship W3136124773A5035152212 @default.
• W3136124773 hasAuthorship W3136124773A5076157457 @default.
• W3136124773 hasAuthorship W3136124773A5083733382 @default.
• W3136124773 hasAuthorship W3136124773A5088579117 @default.
• W3136124773 hasBestOaLocation W31361247731 @default.
• W3136124773 hasConcept C119060515 @default.
• W3136124773 hasConcept C126322002 @default.
• W3136124773 hasConcept C134018914 @default.
• W3136124773 hasConcept C167135981 @default.
• W3136124773 hasConcept C17923572 @default.
• W3136124773 hasConcept C207103383 @default.
• W3136124773 hasConcept C2776301958 @default.
• W3136124773 hasConcept C2778661090 @default.
• W3136124773 hasConcept C2778810321 @default.
• W3136124773 hasConcept C2779161974 @default.
• W3136124773 hasConcept C2779915747 @default.
• W3136124773 hasConcept C2780638905 @default.
• W3136124773 hasConcept C2908647359 @default.
• W3136124773 hasConcept C44249647 @default.
• W3136124773 hasConcept C555293320 @default.
• W3136124773 hasConcept C71924100 @default.
• W3136124773 hasConcept C99454951 @default.
• W3136124773 hasConceptScore W3136124773C119060515 @default.
• W3136124773 hasConceptScore W3136124773C126322002 @default.
• W3136124773 hasConceptScore W3136124773C134018914 @default.
• W3136124773 hasConceptScore W3136124773C167135981 @default.
• W3136124773 hasConceptScore W3136124773C17923572 @default.
• W3136124773 hasConceptScore W3136124773C207103383 @default.
• W3136124773 hasConceptScore W3136124773C2776301958 @default.

• next